Showing results (151-160 of 13,508) with videos related to
Sort By:
Pageof 1,351
Annals of Neurology|August 1, 1983
Combined short-term immunotherapy for experimental autoimmune myasthenia gravisA Pestronk, D B Drachman, R Teoh, et al.Archives of Neurology|December 1, 1987
Vacuolar change in Alzheimer's diseaseT W Smith, U Anwer, U DeGirolami, et al.Experimental Neurology|January 1, 1988
Effect of ketoleucine treatment on atrophy of skeletal muscleW C Yee, D B Drachman, M Walser, et al.Clinical Immunology and Immunopathology|February 1, 1985
Treatment of experimental myasthenia gravis with cyclosporin AD B Drachman, R N Adams, K McIntosh, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptorsR W Kuncl, D B Drachman, R Adams, et al.Neurology|January 1, 1989
Thalamic dementia and motor neuron diseaseF Deymeer, T W Smith, U DeGirolami, et al.Leukemia|May 10, 2000
CDP/Cut DNA binding activity is down-modulated in granulocytes, macrophages and erythrocytes but remains elevated in differentiating megakaryocytesN Martin-Soudant, J G Drachman, K Kaushansky, et al.Toxins|November 10, 2011
Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progressDaniel B Drachman, Robert N Adams, Uma Balasubramanian, et al.Science (New York, N.Y.)|February 17, 1984
Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervationC G Andrew, D B Drachman, A Pestronk, et al.Muscle & Nerve|January 1, 1989
Silver cholinesterase immunocytochemistry: a new neuromuscular junction stainK Alderson, A Pestronk, W C Yee, et al.Pageof 1,351